The global neurovascular devices market is expected to showcase a considerable growth rate during the forecast period. The rising in the aging population results in the risk of the rising incidence of neurovascular disorders that include stroke. For instance, as per the Internet Stroke Center around 75% of strokes occur in people over the age of 65. Furthermore, the risk of having a stroke doubles after the age of 55. The demand for improved treatment techniques along with rising cases of neurovascular in the elderly population is contributing a considerable revenue share. For instance, the introduction of new flow diversion stent technique, the need to treat 00 aneurysms along with bypass has fallen down.
Browse the full report description of "Global Neurovascular Devices Market Size, Share & Trends Analysis Report by Type (Neurothrombectomy Devices, Cerebral Angioplasty & Stenting Devices, Embolization Devices and Others (Vascular Reconstruction Device)), by Application (Brain Aneurysm, Cerebral Artery Stenosis, Ischemic Strokes, and Other), Forecast Period 2019-2025" at https://www.omrglobal.com/industry-reports/neurovascular-devices-market
The geriatric population aged 65 years and above is anticipated to rise. Old age is considered one of the largest risk factors for developing several diseases includes neurological conditions and cardiovascular. Thus, this factor is expected to drive the growth of the neurovascular devices market during the forecast period. According to Centers for disease control and prevention, in the US every year more than 795,000 people suffer from a stroke. Therefore, the prevalence of movement disabilities owing to stroke and its treatment with enables of embolization coils and stents in hospitals and clinical centers fuel the growth of the neurovascular devices market.
The key therapeutic area targeted by neurovascular diseases is the diagnosis and treatment of both types of strokes such as ischemic stroke and hemorrhagic stroke. Stroke majorly involves the use of neurovascular devices includes balloon catheters, flow diversion devices, guide wires, embolic coils, and stenting systems. The key market players are focusing on the collaboration that results in the investment in R&D activity and enhanced their product portfolio for the development of improved versions of diagnosis tools for advanced treatment of neurovascular diseases. For instance, in July 2017, Johnson and Johnson introduced Cerenovus, a new neurovascular business that focuses on delivering innovative therapies for stroke patients. This product approval enabled the company to enhance its product portfolio and neurovascular care along with targeted investments.
Current Market Trends Covered in the Market Report
Global Neurovascular Devices Market- Segmentation
By Application
By Type
Global Neurovascular Devices Market – Segment by Region
North America
Europe
Asia-Pacific
Rest of the World